Logo image of IBTX

INDEPENDENT BANK GROUP INC (IBTX) Stock Fundamental Analysis

NASDAQ:IBTX - US45384B1061 - Common Stock

60.67 USD
+0.28 (+0.46%)
Last: 12/31/2024, 8:00:02 PM
60.63 USD
-0.04 (-0.07%)
After Hours: 12/31/2024, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, IBTX scores 2 out of 10 in our fundamental rating. IBTX was compared to 393 industry peers in the Banks industry. Both the profitability and financial health of IBTX have multiple concerns. IBTX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

IBTX had positive earnings in the past year.
IBTX had a positive operating cash flow in the past year.
Each year in the past 5 years IBTX has been profitable.
IBTX had a positive operating cash flow in each of the past 5 years.
IBTX Yearly Net Income VS EBIT VS OCF VS FCFIBTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

1.2 Ratios

IBTX's Return On Assets of -2.20% is on the low side compared to the rest of the industry. IBTX is outperformed by 98.99% of its industry peers.
IBTX's Return On Equity of -20.96% is on the low side compared to the rest of the industry. IBTX is outperformed by 98.99% of its industry peers.
Industry RankSector Rank
ROA -2.2%
ROE -20.96%
ROIC N/A
ROA(3y)0.83%
ROA(5y)0.98%
ROE(3y)6.2%
ROE(5y)6.94%
ROIC(3y)N/A
ROIC(5y)N/A
IBTX Yearly ROA, ROE, ROICIBTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

IBTX's Profit Margin has declined in the last couple of years.
IBTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-36.52%
PM growth 5Y-24.46%
GM growth 3YN/A
GM growth 5YN/A
IBTX Yearly Profit, Operating, Gross MarginsIBTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1

2. Health

2.1 Basic Checks

IBTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
IBTX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IBTX has been increased compared to 5 years ago.
Compared to 1 year ago, IBTX has an improved debt to assets ratio.
IBTX Yearly Shares OutstandingIBTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
IBTX Yearly Total Debt VS Total AssetsIBTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

IBTX has a debt to FCF ratio of 12.15. This is a negative value and a sign of low solvency as IBTX would need 12.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.15, IBTX is doing worse than 75.06% of the companies in the same industry.
IBTX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
IBTX has a Debt to Equity ratio of 0.26. This is comparable to the rest of the industry: IBTX outperforms 40.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 12.15
Altman-Z N/A
ROIC/WACCN/A
WACC17.25%
IBTX Yearly LT Debt VS Equity VS FCFIBTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IBTX Yearly Current Assets VS Current LiabilitesIBTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2021 2022 2023 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

IBTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.43%.
IBTX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.80% yearly.
The Revenue has grown by 8.01% in the past year. This is quite good.
IBTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.63% yearly.
EPS 1Y (TTM)-39.43%
EPS 3Y-10.93%
EPS 5Y-5.8%
EPS Q2Q%-36.71%
Revenue 1Y (TTM)8.01%
Revenue growth 3Y-5.48%
Revenue growth 5Y6.63%
Sales Q2Q%-1.95%

3.2 Future

IBTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.84% yearly.
IBTX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.19% yearly.
EPS Next Y-25.82%
EPS Next 2Y11.19%
EPS Next 3Y14.84%
EPS Next 5YN/A
Revenue Next Year-5.75%
Revenue Next 2Y8.16%
Revenue Next 3Y9.19%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBTX Yearly Revenue VS EstimatesIBTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IBTX Yearly EPS VS EstimatesIBTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.82, IBTX can be considered very expensive at the moment.
IBTX's Price/Earnings ratio is rather expensive when compared to the industry. IBTX is more expensive than 82.62% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.14. IBTX is around the same levels.
Based on the Price/Forward Earnings ratio of 14.87, the valuation of IBTX can be described as correct.
Based on the Price/Forward Earnings ratio, IBTX is valued a bit more expensive than 70.53% of the companies in the same industry.
IBTX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.82
Fwd PE 14.87
IBTX Price Earnings VS Forward Price EarningsIBTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBTX indicates a rather expensive valuation: IBTX more expensive than 80.10% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 59.94
EV/EBITDA N/A
IBTX Per share dataIBTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as IBTX's earnings are expected to grow with 14.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.19%
EPS Next 3Y14.84%

4

5. Dividend

5.1 Amount

IBTX has a Yearly Dividend Yield of 2.51%. Purely for dividend investing, there may be better candidates out there.
IBTX's Dividend Yield is slightly below the industry average, which is at 3.30.
Compared to an average S&P500 Dividend Yield of 2.34, IBTX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.51%

5.2 History

The dividend of IBTX is nicely growing with an annual growth rate of 23.11%!
IBTX has paid a dividend for at least 10 years, which is a reliable track record.
IBTX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)23.11%
Div Incr Years0
Div Non Decr Years11
IBTX Yearly Dividends per shareIBTX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

The earnings of IBTX are negative and hence is the payout ratio. IBTX will probably not be able to sustain this dividend level.
IBTX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-15.39%
EPS Next 2Y11.19%
EPS Next 3Y14.84%
IBTX Yearly Income VS Free CF VS DividendIBTX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

INDEPENDENT BANK GROUP INC

NASDAQ:IBTX (12/31/2024, 8:00:02 PM)

After market: 60.63 -0.04 (-0.07%)

60.67

+0.28 (+0.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-21 2024-10-21/amc
Earnings (Next)01-20 2025-01-20/amc
Inst Owners77.53%
Inst Owner Change-30.09%
Ins Owners3.11%
Ins Owner Change0%
Market Cap2.51B
Analysts80
Price Target58.31 (-3.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.51%
Yearly Dividend1.52
Dividend Growth(5Y)23.11%
DP-15.39%
Div Incr Years0
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.55%
Min EPS beat(2)-28.26%
Max EPS beat(2)1.17%
EPS beat(4)2
Avg EPS beat(4)-7.83%
Min EPS beat(4)-28.26%
Max EPS beat(4)4.56%
EPS beat(8)3
Avg EPS beat(8)-5.37%
EPS beat(12)5
Avg EPS beat(12)-3.26%
EPS beat(16)7
Avg EPS beat(16)-2.85%
Revenue beat(2)0
Avg Revenue beat(2)-4.46%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-3.51%
Revenue beat(4)0
Avg Revenue beat(4)-5.69%
Min Revenue beat(4)-7.43%
Max Revenue beat(4)-3.51%
Revenue beat(8)0
Avg Revenue beat(8)-6.9%
Revenue beat(12)0
Avg Revenue beat(12)-5.13%
Revenue beat(16)0
Avg Revenue beat(16)-4.72%
PT rev (1m)2.69%
PT rev (3m)1.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 25.82
Fwd PE 14.87
P/S 4.28
P/FCF 59.94
P/OCF 44.69
P/B 1.29
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)2.35
EY3.87%
EPS(NY)4.08
Fwd EY6.72%
FCF(TTM)1.01
FCFY1.67%
OCF(TTM)1.36
OCFY2.24%
SpS14.18
BVpS47.03
TBVpS34.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.2%
ROE -20.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 7.14%
ROA(3y)0.83%
ROA(5y)0.98%
ROE(3y)6.2%
ROE(5y)6.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-36.52%
PM growth 5Y-24.46%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 12.15
Debt/EBITDA N/A
Cap/Depr 45.25%
Cap/Sales 2.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC17.25%
ROIC/WACCN/A
Cap/Depr(3y)194.46%
Cap/Depr(5y)158.96%
Cap/Sales(3y)8.88%
Cap/Sales(5y)7.12%
Profit Quality(3y)168.82%
Profit Quality(5y)129.43%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.43%
EPS 3Y-10.93%
EPS 5Y-5.8%
EPS Q2Q%-36.71%
EPS Next Y-25.82%
EPS Next 2Y11.19%
EPS Next 3Y14.84%
EPS Next 5YN/A
Revenue 1Y (TTM)8.01%
Revenue growth 3Y-5.48%
Revenue growth 5Y6.63%
Sales Q2Q%-1.95%
Revenue Next Year-5.75%
Revenue Next 2Y8.16%
Revenue Next 3Y9.19%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.51%
FCF growth 3Y2.7%
FCF growth 5Y3.65%
OCF growth 1Y-73.99%
OCF growth 3Y2.32%
OCF growth 5Y0.81%